Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Could supplements be the next big opportunity in the GLP-1 weight-loss drug boom?

Novonesis is exploring whether gut health supplements could benefit patients taking GLP-1 weight-loss drugs, opening up a potentially lucrative new market.

We haven't written up this one. CNBC World has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at cnbc.com →

More in Finance & Markets

More from Monday 9 November →